Literature DB >> 26190679

The emergence of metabolomics as a key discipline in the drug discovery process.

Marianne Fillet1, Michel Frédérich2.   

Abstract

Metabolomics is a recent science that could be defined as the comprehensive qualitative and quantitative analysis of all small molecular weight compounds present in a cell, organ (including biofluids) or organism at a specific time point. More and more applications have been found these past years to metabolomics in the pharmaceutical field. Specifically in the drug discovery process, metabolomics open new perspectives, in new targets identification, in toxicological studies and in bioactive natural products discovery. The challenge in metabolomics is to find a technological approach allowing the reproducible identification and quantitation of as much metabolites as possible. In this context, mass spectrometry and NMR are emerging as key and complementary technologies.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Mesh:

Year:  2015        PMID: 26190679     DOI: 10.1016/j.ddtec.2015.01.006

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN: 1740-6749


  12 in total

Review 1.  Rapid ex vivo molecular fingerprinting of biofluids using laser-assisted rapid evaporative ionization mass spectrometry.

Authors:  Vera Plekhova; Lieven Van Meulebroek; Marilyn De Graeve; Alvaro Perdones-Montero; Margot De Spiegeleer; Ellen De Paepe; Emma Van de Walle; Zoltan Takats; Simon J S Cameron; Lynn Vanhaecke
Journal:  Nat Protoc       Date:  2021-08-02       Impact factor: 13.491

Review 2.  Recent metabolomics and gene editing approaches for synthesis of microbial secondary metabolites for drug discovery and development.

Authors:  Rajeshwari Sinha; Babita Sharma; Arun Kumar Dangi; Pratyoosh Shukla
Journal:  World J Microbiol Biotechnol       Date:  2019-10-22       Impact factor: 3.312

Review 3.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 4.  Integrated Approaches to Drug Discovery for Oxidative Stress-Related Retinal Diseases.

Authors:  Yuhei Nishimura; Hideaki Hara
Journal:  Oxid Med Cell Longev       Date:  2016-12-07       Impact factor: 6.543

Review 5.  "Omics"-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives.

Authors:  Holly Matthews; James Hanison; Niroshini Nirmalan
Journal:  Proteomes       Date:  2016-09-12

6.  UPLC-Q-TOF/MS-based metabonomic studies on the intervention effects of aspirin eugenol ester in atherosclerosis hamsters.

Authors:  Ning Ma; Yajun Yang; Xiwang Liu; Xiaojun Kong; Shihong Li; Zhe Qin; Zenghua Jiao; Jianyong Li
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

7.  Non-targeted Metabolite Profiling and Scavenging Activity Unveil the Nutraceutical Potential of Psyllium (Plantago ovata Forsk).

Authors:  Manish K Patel; Avinash Mishra; Bhavanath Jha
Journal:  Front Plant Sci       Date:  2016-04-05       Impact factor: 5.753

8.  Untargetted Metabolomic Exploration of the Mycobacterium tuberculosis Stress Response to Cinnamon Essential Oil.

Authors:  Elwira Sieniawska; Rafał Sawicki; Joanna Golus; Milen I Georgiev
Journal:  Biomolecules       Date:  2020-02-26

Review 9.  Application of metabolomics to drug discovery and understanding the mechanisms of action of medicinal plants with anti-tuberculosis activity.

Authors:  Naasson Tuyiringire; Deusdedit Tusubira; Jean-Pierre Munyampundu; Casim Umba Tolo; Claude M Muvunyi; Patrick Engeu Ogwang
Journal:  Clin Transl Med       Date:  2018-10-01

10.  Neuroprotective Effect of Cyperi rhizome against Corticosterone-Induced PC12 Cell Injury via Suppression of Ca2+ Overloading.

Authors:  Hongmei Jia; Yang Liu; Meng Yu; Hai Shang; Hongwu Zhang; Liyan Ma; Tao Zhang; Zhongmei Zou
Journal:  Metabolites       Date:  2019-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.